Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.5 (
thrombin
)
33,306
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Platelet inositol hexakisphosphate kinase 1 (
IP6K1
) has been shown to control systemic inflammation. Herein, we examined if platelets and
IP6K1
regulate pancreatic tissue injury via formation of NETs in experimental models of acute pancreatitis (AP) in mice. By use of electron microscopy abundant NET formation was observed in the inflamed pancreas. These NETs contained numerous microparticles (MP) expressing CD41 or Mac-1. Platelet depletion reduced deposition of NET-MP complexes in the inflamed pancreas. Circulating platelet-neutrophil aggregates (PNA) were increased and inhibition of P-selectin not only disrupted PNA formation but also reduced NETs formation in the inflamed pancreas. NETs depleted of MPs had lower capacity to provoke amylase secretion and STAT-3 phosphorylation in acinar cells. Taurocholate-induced NETs formation, inflammation and tissue damage in the pancreas were decreased in
IP6K1
-deficient mice. Thrombin stimulation of mixtures of wild-type platelets and neutrophils resulted in NETs formation but not when
IP6K1
-deficient platelets were incubated with wild-type neutrophils. Polyphosphate rescue restored
thrombin
-induced NET formation in mixtures of
IP6K1
-deficient platelets and wild-type neutrophils. Platelet
IP6K1
regulates NET-MP complex formation in the pancreas of mice during induction of AP. Targeting platelet
IP6K1
might useful to decrease NET-dependent pancreatic tissue inflammation and tissue injury in patients with AP.
...
PMID:Platelet IP6K1 regulates neutrophil extracellular trap-microparticle complex formation in acute pancreatitis. 3180 10